We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AXIA6:BMFBOVESPAAXIA Energia SA Non-Cum Perp Pfd Registered Shs Analysis

Data as of 2026-06-15 - not real-time

R$55.78

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

AXIA Energia SA trades at BRL 55.78, well below its DCF fair value of roughly BRL 118, delivering an implied upside of about 38%. The stock’s price is under the 20‑day and 50‑day SMAs (57.7 and 63.6) but above the 200‑day SMA (54.9), while the RSI sits at 30.5, hinting at oversold conditions. Technical momentum turned modestly bullish as the MACD histogram crossed positive and the MACD signal is flagged bullish, supporting a potential short‑term rebound from the current support around BRL 55.2.
Fundamentally, AXIA posted a 22% YoY revenue surge and a 60% YoY jump in EBITDA, with EPS beating forecasts by 14%. However, the balance sheet is leveraged (debt roughly four times cash) and free cash flow is negative, raising questions about the sustainability of its 10% dividend yield and a 91% payout ratio. Analyst consensus remains strongly positive (strong‑buy) with target prices near BRL 77‑79, suggesting the market still sees significant long‑run upside despite short‑term valuation and cash‑flow concerns.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • RSI near oversold and bullish MACD signal
  • Price close to technical support level
  • Recent EPS beat indicating earnings resilience

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue and EBITDA growth
  • High dividend yield relative to peers
  • Analyst consensus (strong‑buy) and target price upside

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Extensive renewable generation assets providing stable cash flows
  • Undervalued valuation metrics (low PE vs industry, DCF upside)
  • Sector tailwinds for clean energy in Brazil

Key Metrics & Analysis

Financial Health

Revenue Growth22.10%
Profit Margin21.89%
P/E Ratio12.7
ROE7.86%
ROA1.97%
Debt/Equity64.67
P/B Ratio1.3
Op. Cash FlowR$14.1B
Free Cash FlowR$-425324864
Industry P/E20.7

Technical Analysis

TrendNeutral
RSI30.5
SupportR$55.19
ResistanceR$60.93
MA 20R$57.72
MA 50R$63.57
MA 200R$54.89
MACDBullish
VolumeIncreasing
Fear & Greed Index92.86

Valuation

Fair ValueR$117.84
Target PriceR$76.99
Upside/Downside38.02%
GradeUndervalued
TypeBlend
Dividend Yield10.46%

Risk Assessment

Beta0.69
Volatility30.96%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.